TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma.

Xuyang Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.